Smith RL - Search Results

1

Absence of correlation between the oral pharmacokinetics and response to bethanidine [proceedings].

Dring LG, Kamanyiro GH, Lancaster R, Smith RL. Dring LG, et al. Among authors: smith rl. Br J Clin Pharmacol. 1977 Jun;4(3):390P-391P. doi: 10.1111/j.1365-2125.1977.tb00738.x. Br J Clin Pharmacol. 1977. PMID: 901715 Free article. No abstract available.

2

The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline [proceedings].

Caldwell J, Lancaster R, Monks TJ, Smith RL. Caldwell J, et al. Among authors: smith rl. Br J Clin Pharmacol. 1977 Oct;4(5):637P-638P. doi: 10.1111/j.1365-2125.1977.tb00809.x. Br J Clin Pharmacol. 1977. PMID: 911622 Free article. No abstract available.

3

Proceedings: A correlation between the response to debrisoquine and the amount of unchanged drug excreted in the urine.

Angelo M, Dring LG, Lancaster R, Latham A, Smith RL. Angelo M, et al. Among authors: smith rl. Br J Pharmacol. 1975 Oct;55(2):264P. Br J Pharmacol. 1975. PMID: 1201404 Free PMC article. No abstract available.

4

The metabolism of [14C]-debrisoquine in man.

Idle JR, Mahgoub A, Angelo MM, Dring LG, Lancaster R, Smith RL. Idle JR, et al. Among authors: smith rl. Br J Clin Pharmacol. 1979 Mar;7(3):257-66. doi: 10.1111/j.1365-2125.1979.tb00930.x. Br J Clin Pharmacol. 1979. PMID: 371651 Free PMC article.

5

The elimination of practolol by two human subjects.

Dring LG, Gorchein A, Mahgoub AA, Smith RL. Dring LG, et al. Among authors: smith rl. Br J Clin Pharmacol. 1978 Mar;5(3):262-5. doi: 10.1111/j.1365-2125.1978.tb01635.x. Br J Clin Pharmacol. 1978. PMID: 148896 Free PMC article. No abstract available.

6

Genetically determined oxidation capacity and the disposition of debrisoquine.

Sloan TP, Lancaster R, Shah RR, Idle JR, Smith RL. Sloan TP, et al. Among authors: smith rl. Br J Clin Pharmacol. 1983 Apr;15(4):443-50. doi: 10.1111/j.1365-2125.1983.tb01528.x. Br J Clin Pharmacol. 1983. PMID: 6849780 Free PMC article.

7

Polymorphic hydroxylation of Debrisoquine in man.

Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL. Mahgoub A, et al. Among authors: smith rl. Lancet. 1977 Sep 17;2(8038):584-6. doi: 10.1016/s0140-6736(77)91430-1. Lancet. 1977. PMID: 71400

8

Polymorphism of carbon oxidation of drugs and clinical implications.

Sloan TP, Mahgoub A, Lancaster R, Idle JR, Smith RL. Sloan TP, et al. Among authors: smith rl. Br Med J. 1978 Sep 2;2(6138):655-7. doi: 10.1136/bmj.2.6138.655. Br Med J. 1978. PMID: 151576 Free PMC article.

9

The fate of lysergic acid DI[14C]ethylamide ([14C]LSD) in the rat, guinea pig and rhesus monkey and of [14C]iso-LSD in rat.

Siddik ZH, Barnes RD, Dring LG, Smith RL, Williams RT. Siddik ZH, et al. Among authors: smith rl. Biochem Pharmacol. 1979 Oct 15;28(20):3093-101. doi: 10.1016/0006-2952(79)90618-x. Biochem Pharmacol. 1979. PMID: 117811 No abstract available.

10

Hypotensive response to debrisoquine and hydroxylation phenotype.

Idle JR, Mahgoub A, Lancaster R, Smith RL. Idle JR, et al. Among authors: smith rl. Life Sci. 1978 Mar;22(11):979-83. doi: 10.1016/0024-3205(78)90363-6. Life Sci. 1978. PMID: 642709 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,623 results

Search Page